This opportunity funds pilot projects aimed at elucidating the role of understudied proteins associated with rare diseases. It supports basic biochemical and biological research to generate preliminary data and tools, focusing on eligible druggable proteins linked to rare diseases. Clinical trials are not allowed under this funding.
Eligible applicants include a wide range of U.S. entities such as federally recognized Native American tribal governments, public and private institutions of higher education, nonprofits, small businesses, and various government bodies. Eligibility is limited to U.S.-based organizations.
